Roland Kontermann

Roland Kontermann

Universität Stuttgart

H-index: 58

Europe-Germany

About Roland Kontermann

Roland Kontermann, With an exceptional h-index of 58 and a recent h-index of 35 (since 2020), a distinguished researcher at Universität Stuttgart, specializes in the field of antibody engineering.

His recent articles reflect a diverse array of research interests and contributions to the field:

Multivalent binding molecules

Tumor necrosis factor receptor 2 activation elicits sex-specific effects on cortical myelin proteins and functional recovery in a model of multiple sclerosis

The present and future of bispecific antibodies for cancer therapy

The TNFR1 antagonist Atrosimab reduces neuronal loss, glial activation and memory deficits in an acute mouse model of neurodegeneration

Sequential treatment with a TNFR2 agonist and a TNFR1 antagonist improves outcomes in a humanized mouse model for MS

eIg-based bispecific T-cell engagers targeting EGFR: format matters

Co-modulation of TNFR1 and TNFR2 in an animal model of multiple sclerosis

Heterodimerizing Ig domains

Roland Kontermann Information

University

Position

___

Citations(all)

13653

Citations(since 2020)

5261

Cited By

10296

hIndex(all)

58

hIndex(since 2020)

35

i10Index(all)

156

i10Index(since 2020)

109

Email

University Profile Page

Universität Stuttgart

Google Scholar

View Google Scholar Profile

Roland Kontermann Skills & Research Interests

antibody engineering

Top articles of Roland Kontermann

Title

Journal

Author(s)

Publication Date

Multivalent binding molecules

2024/2/22

Tumor necrosis factor receptor 2 activation elicits sex-specific effects on cortical myelin proteins and functional recovery in a model of multiple sclerosis

Brain research bulletin

Kayla L Nguyen

Ishaan J Bhatt

Shruti Gupta

Nazaf Showkat

Kathryn A Swanson

...

2024/2/1

The present and future of bispecific antibodies for cancer therapy

Christian Klein

Ulrich Brinkmann

Janice M Reichert

Roland E Kontermann

2024/3/6

The TNFR1 antagonist Atrosimab reduces neuronal loss, glial activation and memory deficits in an acute mouse model of neurodegeneration

Scientific reports

Natalia Ortí-Casañ

Ate S Boerema

Karina Köpke

Amber Ebskamp

Jan Keijser

...

2023/6/30

Sequential treatment with a TNFR2 agonist and a TNFR1 antagonist improves outcomes in a humanized mouse model for MS

Journal of neuroinflammation

Valentina Pegoretti

Jan Bauer

Roman Fischer

Iskra Paro

Wanda Douwenga

...

2023/5/3

eIg-based bispecific T-cell engagers targeting EGFR: format matters

MAbs

Lennart Kühl

Annelie K Schäfer

Sebastian Kraft

Nadine Aschmoneit

Roland E Kontermann

...

2023/12/31

Co-modulation of TNFR1 and TNFR2 in an animal model of multiple sclerosis

Journal of neuroinflammation

Timon Fiedler

Richard Fairless

Kira Pichi

Roman Fischer

Fabian Richter

...

2023/4/30

Heterodimerizing Ig domains

2023/12/26

Intrathymic dendritic cell-biased precursors promote human T cell lineage specification through IRF8-driven transmembrane TNF

Nature immunology

Kai Ling Liang

Juliette Roels

Marieke Lavaert

Tom Putteman

Lena Boehme

...

2023/3

Evaluation of the neutralizing antibody STE90-C11 against SARS-CoV-2 delta infection and its recognition of other variants of concerns

Viruses

Leila Abassi

Federico Bertoglio

Željka Mačak Šafranko

Thomas Schirrmann

Marina Greweling-Pils

...

2023/10/25

Quantification of intratumoural heterogeneity in mice and patients via machine-learning models trained on PET–MRI data

Nature Biomedical Engineering

Prateek Katiyar

Johannes Schwenck

Leonie Frauenfeld

Mathew R Divine

Vaibhav Agrawal

...

2023/8

Mammalian display platform for the maturation of bispecific TCR-based molecules

Antibodies

Janine Dilchert

Martin Hofmann

Felix Unverdorben

Roland Kontermann

Sebastian Bunk

2022/5/10

Fc-based Duokines: dual-acting costimulatory molecules comprising TNFSF ligands in the single-chain format fused to a heterodimerizing Fc (scDk-Fc)

Oncoimmunology

Nadine Aschmoneit

Katharina Kocher

Martin Siegemund

Martina S Lutz

Lennart Kühl

...

2022/12/31

Triple targeting of HER receptors overcomes heregulin-mediated resistance to EGFR blockade in colorectal cancer

Molecular Cancer Therapeutics

Alexander Rau

Nicole Janssen

Lennart Kühl

Thomas Sell

Svetlana Kalmykova

...

2022/5/4

Trivalent binding molecules

2022/12/15

Focal adhesion kinase plays a dual role in TRAIL resistance and metastatic outgrowth of malignant melanoma

Cell Death & Disease

Greta Del Mistro

Shamala Riemann

Sebastian Schindler

Stefan Beissert

Roland E Kontermann

...

2022/1/12

Binding modules comprising modified ehd2 domains

2022/11/24

TNFR2 Agonists with Improved Stability

2022/8/25

GlycoTAIL and FlexiTAIL as half-life extension modules for recombinant antibody fragments

Molecules

Oliver Seifert

Roland E Kontermann

2022/5/19

The eIg technology to generate Ig-like bispecific antibodies

Mabs

Lennart Kühl

Nadine Aschmoneit

Roland E Kontermann

Oliver Seifert

2022/12/31

See List of Professors in Roland Kontermann University(Universität Stuttgart)

Co-Authors

H-index: 103
Greg Winter

Greg Winter

University of Cambridge

H-index: 86
Frank Allgöwer

Frank Allgöwer

Universität Stuttgart

H-index: 83
Robert Hawkins

Robert Hawkins

Manchester University

H-index: 56
Juergen Pleiss

Juergen Pleiss

Universität Stuttgart

H-index: 45
Eisel ULM

Eisel ULM

Rijksuniversiteit Groningen

H-index: 38
Oliver Hartley

Oliver Hartley

Université de Genève

academic-engine